Spinal Muscular Atrophy (SMA) Treatment Market Report

Global and Region Spinal Muscular Atrophy (SMA) Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：221
  • REPORT CODE：GMM885930
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Spinal muscular atrophy (SMA) refers to a group of inherited diseases that affects the functioning of muscles because of deterioration.

    North America dominates the global market for SMA treatment due to the high prevalence of SMA and increased adoption of SMA treatment options in the region.

    The report details the trend, potential and market size of Spinal Muscular Atrophy (SMA) Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Spinal Muscular Atrophy (SMA) Treatmentmarket, defines the market attractiveness level of Spinal Muscular Atrophy (SMA) Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Spinal Muscular Atrophy (SMA) Treatment industry, describes the types of Spinal Muscular Atrophy (SMA) Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Spinal Muscular Atrophy (SMA) Treatment market and the development prospects and opportunities of Spinal Muscular Atrophy (SMA) Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Spinal Muscular Atrophy (SMA) Treatment market in Chapter 13.

    By Player:

    • Biogen Idec

    • Pfizer

    • Roche

    • Novartis

    • Scholor Rock

    • Isis Pharmaceuticals

    • Ionis Pharmaceuticals

    By Type:

    • Type I Spinal Muscular Atrophy (SMA)

    • Type II Spinal Muscular Atrophy (SMA)

    • Type III Spinal Muscular Atrophy (SMA)

    By End-User:

    • Hospitals

    • Ambulatory Surgical Centers

    • Diagnostic Centers

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Spinal Muscular Atrophy (SMA) Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Spinal Muscular Atrophy (SMA) Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Spinal Muscular Atrophy (SMA) Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Spinal Muscular Atrophy (SMA) Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Spinal Muscular Atrophy (SMA) Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Spinal Muscular Atrophy (SMA) Treatment Consumption (2017-2022)

    • 7.2 United States Spinal Muscular Atrophy (SMA) Treatment Consumption (2017-2022)

    • 7.3 Europe Spinal Muscular Atrophy (SMA) Treatment Consumption (2017-2022)

    • 7.4 China Spinal Muscular Atrophy (SMA) Treatment Consumption (2017-2022)

    • 7.5 Japan Spinal Muscular Atrophy (SMA) Treatment Consumption (2017-2022)

    • 7.6 India Spinal Muscular Atrophy (SMA) Treatment Consumption (2017-2022)

    • 7.7 South Korea Spinal Muscular Atrophy (SMA) Treatment Consumption (2017-2022)

    8 Region and Country-wise Spinal Muscular Atrophy (SMA) Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Spinal Muscular Atrophy (SMA) Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Spinal Muscular Atrophy (SMA) Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Spinal Muscular Atrophy (SMA) Treatment Consumption Forecast (2022-2028)

    • 8.4 China Spinal Muscular Atrophy (SMA) Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Spinal Muscular Atrophy (SMA) Treatment Consumption Forecast (2022-2028)

    • 8.6 India Spinal Muscular Atrophy (SMA) Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Spinal Muscular Atrophy (SMA) Treatment Consumption Forecast (2022-2028)

    9 Global Spinal Muscular Atrophy (SMA) Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Spinal Muscular Atrophy (SMA) Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Type I Spinal Muscular Atrophy (SMA) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Type II Spinal Muscular Atrophy (SMA) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Type III Spinal Muscular Atrophy (SMA) Consumption and Growth Rate (2017-2022)

    • 9.2 Global Spinal Muscular Atrophy (SMA) Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Diagnostic Centers Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Spinal Muscular Atrophy (SMA) Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Spinal Muscular Atrophy (SMA) Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Type I Spinal Muscular Atrophy (SMA) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Type II Spinal Muscular Atrophy (SMA) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Type III Spinal Muscular Atrophy (SMA) Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Spinal Muscular Atrophy (SMA) Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Spinal Muscular Atrophy (SMA) Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Spinal Muscular Atrophy (SMA) Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Spinal Muscular Atrophy (SMA) Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Spinal Muscular Atrophy (SMA) Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Spinal Muscular Atrophy (SMA) Treatment Market Competitive Analysis

    • 14.1 Biogen Idec

      • 14.1.1 Biogen Idec Company Details

      • 14.1.2 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Product and Service

    • 14.2 Pfizer

      • 14.2.1 Pfizer Company Details

      • 14.2.2 Pfizer Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pfizer Spinal Muscular Atrophy (SMA) Treatment Product and Service

    • 14.3 Roche

      • 14.3.1 Roche Company Details

      • 14.3.2 Roche Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Roche Spinal Muscular Atrophy (SMA) Treatment Product and Service

    • 14.4 Novartis

      • 14.4.1 Novartis Company Details

      • 14.4.2 Novartis Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Novartis Spinal Muscular Atrophy (SMA) Treatment Product and Service

    • 14.5 Scholor Rock

      • 14.5.1 Scholor Rock Company Details

      • 14.5.2 Scholor Rock Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Scholor Rock Spinal Muscular Atrophy (SMA) Treatment Product and Service

    • 14.6 Isis Pharmaceuticals

      • 14.6.1 Isis Pharmaceuticals Company Details

      • 14.6.2 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product and Service

    • 14.7 Ionis Pharmaceuticals

      • 14.7.1 Ionis Pharmaceuticals Company Details

      • 14.7.2 Ionis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Ionis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Spinal Muscular Atrophy (SMA) Treatment

    • Figure Spinal Muscular Atrophy (SMA) Treatment Picture

    • Table Global Spinal Muscular Atrophy (SMA) Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Spinal Muscular Atrophy (SMA) Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Spinal Muscular Atrophy (SMA) Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Spinal Muscular Atrophy (SMA) Treatment Consumption by Country (2017-2022)

    • Figure United States Spinal Muscular Atrophy (SMA) Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Spinal Muscular Atrophy (SMA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Spinal Muscular Atrophy (SMA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Spinal Muscular Atrophy (SMA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Spinal Muscular Atrophy (SMA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Spinal Muscular Atrophy (SMA) Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Spinal Muscular Atrophy (SMA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Spinal Muscular Atrophy (SMA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Spinal Muscular Atrophy (SMA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Spinal Muscular Atrophy (SMA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Spinal Muscular Atrophy (SMA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Spinal Muscular Atrophy (SMA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type I Spinal Muscular Atrophy (SMA) Consumption and Growth Rate (2017-2022)

    • Figure Global Type II Spinal Muscular Atrophy (SMA) Consumption and Growth Rate (2017-2022)

    • Figure Global Type III Spinal Muscular Atrophy (SMA) Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Type I Spinal Muscular Atrophy (SMA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type II Spinal Muscular Atrophy (SMA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type III Spinal Muscular Atrophy (SMA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Spinal Muscular Atrophy (SMA) Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Spinal Muscular Atrophy (SMA) Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Biogen Idec (Foundation Year, Company Profile and etc.)

    • Table Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Spinal Muscular Atrophy (SMA) Treatment Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Spinal Muscular Atrophy (SMA) Treatment Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Spinal Muscular Atrophy (SMA) Treatment Product and Service

    • Table Scholor Rock (Foundation Year, Company Profile and etc.)

    • Table Scholor Rock Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Scholor Rock Spinal Muscular Atrophy (SMA) Treatment Product and Service

    • Table Isis Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product and Service

    • Table Ionis Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Ionis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ionis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US